Literature DB >> 12235170

Uptake of long-chain fatty acids in HepG2 cells involves caveolae: analysis of a novel pathway.

Jürgen Pohl1, Axel Ring, Wolfgang Stremmel.   

Abstract

We investigated the role of caveolae in uptake and intracellular trafficking of long chain fatty acids (LCFA) in HepG2 human hepatoma cells. The uptake of [(3)H]oleic acid and [(3)H]stearic acid into HepG2 cells was measured by radioactive assays and internalization of the non-metabolizable fluorescent fatty acid 12-(N-methyl)-N-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino] (12-NBD) stearate into single HepG2 cells was semi-quantitatively assessed by laser scanning microscopy. The initial rate of [(3)H]oleic acid uptake (V(0)) in HepG2 cells exhibited saturable transport kinetics with increasing concentrations of free oleic acid (V(max) 854 +/- 46 pmol mg protein(-1) min(-1), K(m) 100 +/- 14 nmol/l). While inhibition of clathrin coated pits did not influence LCFA uptake in HepG2, inhibition of caveolae formation by filipin III, cyclodextrin, and caveolin-1 antisense oligonucleotides resulted in reduction of [(3)H]oleic acid uptake by 54%, 45%, and 23%, respectively. Furthermore, filipin III inhibited the uptake of [(3)H]stearic acid and its fluorescent derivative 12-NBD stearate by 44% and 50%, respectively. Transfection studies with alpha-caveolin-1/cyanofluorescent protein chimeras showed significant colocalization of caveolae and internalized 12-NBD stearate. In conclusion, these data suggest a significant role for caveolae mediated uptake and intracellular trafficking of LCFA in HepG2 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12235170     DOI: 10.1194/jlr.m100404-jlr200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  33 in total

1.  The role of proline in the membrane re-entrant helix of caveolin-1.

Authors:  Satoko Aoki; Annick Thomas; Marc Decaffmeyer; Robert Brasseur; Richard M Epand
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

2.  Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.

Authors:  Dodie S Pouniotis; Vasso Apostolopoulos; Geoffrey A Pietersz
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

Review 3.  The life of lipid droplets.

Authors:  Tobias C Walther; Robert V Farese
Journal:  Biochim Biophys Acta       Date:  2008-11-07

Review 4.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

5.  The mechanism of polyplex internalization into cells: testing the GM1/caveolin-1 lipid raft mediated endocytosis pathway.

Authors:  Rong Qi; Douglas G Mullen; James R Baker; Mark M Banaszak Holl
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

6.  Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice.

Authors:  Fengxia Ge; Shengli Zhou; Chunguang Hu; Harrison Lobdell; Paul D Berk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-01       Impact factor: 4.052

7.  Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.

Authors:  Dodie Pouniotis; Choon-Kit Tang; Vasso Apostolopoulos; Geoffrey Pietersz
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

8.  Effects of ranolazine on fatty acid transformation in the isolated perfused rat liver.

Authors:  Márcio Shigueaki Mito; Jorgete Constantin; Cristiane Vizioli de Castro; Nair Seiko Yamamoto; Adelar Bracht
Journal:  Mol Cell Biochem       Date:  2010-08-01       Impact factor: 3.396

9.  Membrane binding proteins are the major determinants for the hepatocellular transmembrane flux of long-chain fatty acids bound to albumin.

Authors:  G Rajaraman; M S Roberts; D Hung; G Q Wang; F J Burczynski
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

Review 10.  Nonalcoholic Fatty Liver Disease: Lipids and Insulin Resistance.

Authors:  Paul D Berk; Elizabeth C Verna
Journal:  Clin Liver Dis       Date:  2016-02-18       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.